Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Diabetology & Metabolic Syndrome
|
June 29, 2019
Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
Davide Maggi, Fabrizio Montecucco, Gianfranco Adami, et al.
Biochemical and Biophysical Research Communications
|
August 16, 2005
Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent
Barbara Salani, Silvia Repetto, Renzo Cordera, et al.
Diabetes Care
|
July 25, 2015
Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149
Chiara Mazzucchelli, Caterina Bordone, Davide Maggi, et al.
Biochemical and Biophysical Research Communications
|
October 18, 2005
Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism
Silvia Repetto, Barbara Salani, Davide Maggi, et al.
Obesity Surgery
|
January 20, 2017
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion
Nicola Scopinaro, Gian Franco Adami, Paolo Bruzzi, et al.
Endocrinology
|
November 28, 2007
Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts
Barbara Salani, Lucia Briatore, Silvano Garibaldi, et al.
Biochemical and Biophysical Research Communications
|
March 9, 2004
IGF-I regulates caveolin 1 and IRS1 interaction in caveolae
Danilo Panetta, Claudia Biedi, Silvia Repetto, et al.
Endocrinology
|
September 10, 2003
Specificity of insulin-like growth factor I and insulin on Shc phosphorylation and Grb2 recruitment in caveolae
Claudia Biedi, Danilo Panetta, Daniela Segat, et al.
Acta Diabetologica
|
March 12, 2018
Switching from Glargine to Degludec is not associated with an overt change in glucose control in a cohort of patients with type 1 diabetes: a CGM analysis
Laura Affinito Bonabello, Davide Maggi, Samuele Fiorini, et al.
Obesity Surgery
|
June 14, 2019
Adipose Tissue Composition in Obesity and After Bariatric Surgery
Gian Franco Adami, Federico Carbone, Fabrizio Montecucco, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Diabetology & Metabolic Syndrome
|
June 29, 2019
Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
Davide Maggi, Fabrizio Montecucco, Gianfranco Adami, et al.
Biochemical and Biophysical Research Communications
|
August 16, 2005
Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent
Barbara Salani, Silvia Repetto, Renzo Cordera, et al.
Diabetes Care
|
July 25, 2015
Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149
Chiara Mazzucchelli, Caterina Bordone, Davide Maggi, et al.
Biochemical and Biophysical Research Communications
|
October 18, 2005
Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism
Silvia Repetto, Barbara Salani, Davide Maggi, et al.
Obesity Surgery
|
January 20, 2017
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion
Nicola Scopinaro, Gian Franco Adami, Paolo Bruzzi, et al.
Endocrinology
|
November 28, 2007
Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts
Barbara Salani, Lucia Briatore, Silvano Garibaldi, et al.
Biochemical and Biophysical Research Communications
|
March 9, 2004
IGF-I regulates caveolin 1 and IRS1 interaction in caveolae
Danilo Panetta, Claudia Biedi, Silvia Repetto, et al.
Endocrinology
|
September 10, 2003
Specificity of insulin-like growth factor I and insulin on Shc phosphorylation and Grb2 recruitment in caveolae
Claudia Biedi, Danilo Panetta, Daniela Segat, et al.
Acta Diabetologica
|
March 12, 2018
Switching from Glargine to Degludec is not associated with an overt change in glucose control in a cohort of patients with type 1 diabetes: a CGM analysis
Laura Affinito Bonabello, Davide Maggi, Samuele Fiorini, et al.
Obesity Surgery
|
June 14, 2019
Adipose Tissue Composition in Obesity and After Bariatric Surgery
Gian Franco Adami, Federico Carbone, Fabrizio Montecucco, et al.
Page
of 7